Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in sweden.
Laquinimod Halted MS Disability But Not Relapses
Proton Density MRI Increases Detection of Cervical Spinal Cord Multiple Sclerosis Lesions Compared with T2-Weighted Fast Spin-Echo.
Optic neuritis in a child with biotinidase deficiency: case report and literature review.
Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis.
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset.
Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study.
Outcome and survival of asymptomatic PML in natalizumab-treated MS patients.
Confronting the diagnosis of multiple sclerosis: a qualitative study of patient experiences.
Study shows promising efficacy for peginterferon beta-1a in multiple sclerosis
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study.
Regional Cervical Cord Atrophy and Disability in Multiple Sclerosis: A Voxel-based Analysis.
Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve
Transcriptional enhancers: from properties to genome-wide predictions.
Progressive multiple sclerosis: The treatment gap.
Treating multiple sclerosis with monoclonal antibodies: a 2013 update.
The "liberation procedure" for multiple sclerosis: sacrificing science at the altar of consumer demand.
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells.
Platelets provide a bounty of potential targets for therapy in multiple sclerosis.
3H-1,2-dithiole-3-thione as a novel therapeutic agent for the treatment of experimental autoimmune encephalomyelitis.
Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis (PROMESS)
Tractography Analysis of 5 White Matter Bundles and Their Clinical and Cognitive Correlates in Early-Course Schizophrenia.
Rehabilitation in transverse myelitis.

Pages